Lucas Ward
Stock Analyst at Ascendiant Capital
(0)
# 5174
Out of 5,334 analysts
18
Total ratings
30.77%
Success rate
-49.26%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
VVOS Vivos Therapeutics | Maintains: Buy | 7 7 | 3.11 | 99.36% | 3 | Apr 15, 2025 | |
LIQT LiqTech Intl | Reiterates: Strong Buy | 4 4 | 1.44 | 136.11% | 4 | Apr 7, 2025 | |
HSCS HeartSciences | Maintains: Buy | 15 14 | 3.45 | 305.8% | 2 | Mar 18, 2025 | |
ACON Aclarion | Maintains: Buy | 555 481 | n/a | n/a | 3 | Nov 27, 2024 | |
CYTH Cyclo Therapeutics | Maintains: Buy | 3 1 | n/a | n/a | 2 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 3375 2700 | 7.11 | 37874.68% | 2 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 144 | 2.38 | 5950.42% | 1 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 2160 | n/a | n/a | 1 | Mar 6, 2023 |